MaryJWilkinsonMD

Oncology • Washington, DC

Breast Cancer

Physician

Join to view full profile

Dr. Wilkinson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Wilkinson's full profile

Already have an account?

Office
5255 Loughboro Road NW
Washington, DC 20016
Phone+1 202-660-6500

Fax+1 202-660-6501
Is this information wrong?

Education & Training

University of California (San Francisco)Residency, Internal Medicine, 1983 - 1986
Stanford University School of MedicineClass of 1983

Certifications & Licensure

CA State Medical License 1985 - Present
MD State Medical License 2018 - 2025
VA State Medical License 1991 - 2024
DC State Medical License 2019 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Top Doctors:Washington DC Area Castle Connolly, 2012
Top Doctors:Washington-Baltimore Castle Connolly, 2012
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Northern Virginia Magazine Castle Connolly, 2007
Join now to see all

Clinical Trials

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13
Completed
Phase 3
Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial) Start of enrollment: 2009 Dec 01
Completed
Phase 1, Phase 2
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation Start of enrollment: 2012 Aug 01
Completed
Phase 2, Phase 3
S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy Start of enrollment: 2013 May 15
Completed
Phase 3
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
Prevention of Paclitaxel Neuropathy With Cryotherapy Start of enrollment: 2014 Oct 01
Unknown status
Phase 2
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer Start of enrollment: 2017 Jan 18
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

1 citations
Adjuvant treatment decisions among adults aged 65 years and older with early-stage hormone receptor positive breast cancer seen in a simple multidisciplinary clinic ve...
Keara English, Sara R Alcorn, Hanh-Tam Tran, Karen Lisa Smith, Mary Wilkinson, Kelly Tadken Hirose, Maureen O'Donnell, Victoria Croog, Jean L Wright> ;Journal of Geriatric Oncology. 2023 May 1
6 citations
Extended Endocrine Therapy for Early-Stage Breast Cancer: How Do We Decide?
Elaine M. Walsh, Raquel Nunes, Mary Wilkinson, Cesar A. Santa-Maria> ;Current Oncology Reports. 2020 Oct 5
33 citations
Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach.
Jennifer Y. Sheng, Cesar A. Santa-Maria, Neha Mangini, Haval Norman, Rima Couzi, Raquel Nunes, Mary Wilkinson, Kala Visvanathan, RM Connolly, Evanthia T. Roussos Torre...> ;JCO Oncology Practice. 2020 Jun 30
23 citations
Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I); an ACCRU trial.
Kathryn J. Ruddy, Jennifer Le-Rademacher, Mario E. Lacouture, Mary Wilkinson, Adedayo A. Onitilo, Amy C. Vander Woude, Maria T. Grosse-Perdekamp, Travis J. Dockter, An...> ;Breast. 2019 Dec 1
26 citations
Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer.
Claudine Isaacs, Pia Herbolsheimer, Minetta C. Liu, Mary Wilkinson, Yvonne L. Ottaviano, Gina G. Chung, Robert D. Warren, Jennifer Eng-Wong, Philip Cohen, Karen Lisa S...> ;Breast Cancer Research and Treatment. 2011 Jan 1
242 citations
Circulating Tumor Cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast Cancer
Minetta C. Liu, Peter G. Shields, Robert D. Warren, Philip Cohen, Mary Wilkinson, Yvonne L. Ottaviano, Suman B. Rao, Jennifer Eng-Wong, Françoise Seillier-Moiseiwitsch...> ;Journal of Clinical Oncology. 2009 Nov 1
96 citations
The radioisotope contributes significantly to the activity of radioimmunotherapy.
Thomas A. Davis, Mark S. Kaminski, John P. Leonard, Frank J. Hsu, Mary Wilkinson, Andrew D. Zelenetz, Richard L. Wahl, Stewart Kroll, Morton Coleman, Michael L. Goris,...> ;Clinical Cancer Research. 2004 Dec 1
2 citations
A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinoma
Eric J. Small, John W. Frye, Mary J. Wilkinson, Peter R. Carroll, Mary Lou Ernest, Robert J. Stagg> ;Cancer. 1994 Jun 1
12 citations
A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma
Mary J. Wilkinson, John W. Frye, Eric J. Small, Alan P. Venook, Peter R. Carroll, Mary Lou Ernest, Robert J. Stagg> ;Cancer. 1993 Jun 1
2 citations
Use of Biological Response Modifiers for Management of Renal Cell Carcinoma
Mary J. Wilkinson, Frederick R. Aronson> ;Urologia Internationalis. 1991 Jan 1
28 citations
Testicular carcinoma in patients positive and at risk for human immunodeficiency virus.
Mary Wilkinson, Peter R. Carroll> ;The Journal of Urology. 1990 Nov 1
9 citations
A nonradioactive assay for type IV collagen degradation
Mary J. Wilkinson, Robert L. Cohen, Marc A. Shuman> ;Analytical Biochemistry. 1990 Mar 1
Join now to see all

Hospital Affiliations

Reston Hospital CenterReston, Virginia
Johns Hopkins HospitalBaltimore, Maryland
Johns Hopkins Howard County Medical CenterColumbia, Maryland
Sibley Memorial HospitalWashington, District of Columbia
Suburban HospitalBethesda, Maryland

MaryJWilkinsonMD

Dr. Wilkinson is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.